WO2010058049A1 - Préparation de matériaux biocompatibles à partir de déchets issus du processus de fabrication de la bière, et utilisations de ces matériaux - Google Patents
Préparation de matériaux biocompatibles à partir de déchets issus du processus de fabrication de la bière, et utilisations de ces matériaux Download PDFInfo
- Publication number
- WO2010058049A1 WO2010058049A1 PCT/ES2009/070475 ES2009070475W WO2010058049A1 WO 2010058049 A1 WO2010058049 A1 WO 2010058049A1 ES 2009070475 W ES2009070475 W ES 2009070475W WO 2010058049 A1 WO2010058049 A1 WO 2010058049A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- final temperature
- material obtained
- temperature
- stage
- beer
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 42
- 235000013405 beer Nutrition 0.000 title claims abstract description 17
- 230000008569 process Effects 0.000 title abstract description 20
- 239000000560 biocompatible material Substances 0.000 title abstract description 8
- 238000004519 manufacturing process Methods 0.000 title abstract description 5
- 239000002699 waste material Substances 0.000 title abstract description 4
- 238000002360 preparation method Methods 0.000 title description 7
- 210000000988 bone and bone Anatomy 0.000 claims abstract description 16
- 238000010438 heat treatment Methods 0.000 claims abstract description 10
- 238000001035 drying Methods 0.000 claims abstract description 8
- 229910019142 PO4 Inorganic materials 0.000 claims abstract description 7
- 235000021317 phosphate Nutrition 0.000 claims abstract description 7
- 150000003013 phosphoric acid derivatives Chemical class 0.000 claims abstract description 6
- 150000004760 silicates Chemical class 0.000 claims abstract description 6
- 239000000463 material Substances 0.000 claims description 55
- 239000007787 solid Substances 0.000 claims description 18
- 241000609240 Ambelania acida Species 0.000 claims description 14
- 239000010905 bagasse Substances 0.000 claims description 14
- 239000010703 silicon Substances 0.000 claims description 14
- 229910052710 silicon Inorganic materials 0.000 claims description 14
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 13
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 11
- 239000011777 magnesium Substances 0.000 claims description 11
- 229910052749 magnesium Inorganic materials 0.000 claims description 11
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 10
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 10
- 239000011575 calcium Substances 0.000 claims description 10
- 229910052791 calcium Inorganic materials 0.000 claims description 10
- 239000011574 phosphorus Substances 0.000 claims description 10
- 229910052698 phosphorus Inorganic materials 0.000 claims description 10
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 9
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 9
- 239000011591 potassium Substances 0.000 claims description 9
- 229910052700 potassium Inorganic materials 0.000 claims description 9
- 239000011734 sodium Substances 0.000 claims description 9
- 229910052708 sodium Inorganic materials 0.000 claims description 9
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 7
- 239000003054 catalyst Substances 0.000 claims description 6
- 229910052799 carbon Inorganic materials 0.000 claims description 5
- 239000004065 semiconductor Substances 0.000 claims description 5
- 238000000855 fermentation Methods 0.000 claims description 4
- 230000004151 fermentation Effects 0.000 claims description 4
- 239000003440 toxic substance Substances 0.000 claims description 3
- 239000003463 adsorbent Substances 0.000 claims description 2
- 231100000614 poison Toxicity 0.000 claims description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- 239000012620 biological material Substances 0.000 description 7
- 238000012512 characterization method Methods 0.000 description 7
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical class [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 7
- 239000001506 calcium phosphate Substances 0.000 description 6
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- 238000002441 X-ray diffraction Methods 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 235000011010 calcium phosphates Nutrition 0.000 description 5
- 238000011161 development Methods 0.000 description 5
- 230000018109 developmental process Effects 0.000 description 5
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 5
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 5
- 229910052753 mercury Inorganic materials 0.000 description 5
- 238000001179 sorption measurement Methods 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 210000000130 stem cell Anatomy 0.000 description 4
- 238000004438 BET method Methods 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 229910052586 apatite Inorganic materials 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 238000002459 porosimetry Methods 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 235000014653 Carica parviflora Nutrition 0.000 description 2
- 241000243321 Cnidaria Species 0.000 description 2
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical group [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- MCMNRKCIXSYSNV-UHFFFAOYSA-N Zirconium dioxide Chemical compound O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 description 2
- 239000006096 absorbing agent Substances 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 229910000389 calcium phosphate Inorganic materials 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 239000007943 implant Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000000634 powder X-ray diffraction Methods 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 1
- 241000282414 Homo sapiens Species 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 239000004115 Sodium Silicate Substances 0.000 description 1
- BOTDANWDWHJENH-UHFFFAOYSA-N Tetraethyl orthosilicate Chemical compound CCO[Si](OCC)(OCC)OCC BOTDANWDWHJENH-UHFFFAOYSA-N 0.000 description 1
- 238000007171 acid catalysis Methods 0.000 description 1
- 239000002154 agricultural waste Substances 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 150000001448 anilines Chemical class 0.000 description 1
- 210000001557 animal structure Anatomy 0.000 description 1
- 229940098396 barley grain Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- 239000005313 bioactive glass Substances 0.000 description 1
- 239000003462 bioceramic Substances 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 230000033558 biomineral tissue development Effects 0.000 description 1
- 230000010478 bone regeneration Effects 0.000 description 1
- 238000001354 calcination Methods 0.000 description 1
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 description 1
- 239000004068 calcium phosphate ceramic Substances 0.000 description 1
- 229940043256 calcium pyrophosphate Drugs 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 239000003575 carbonaceous material Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 235000019821 dicalcium diphosphate Nutrition 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000002241 glass-ceramic Substances 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000010903 husk Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229910001425 magnesium ion Inorganic materials 0.000 description 1
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical class [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 description 1
- 239000004137 magnesium phosphate Substances 0.000 description 1
- 235000010994 magnesium phosphates Nutrition 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 230000006911 nucleation Effects 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000000278 osteoconductive effect Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 238000013379 physicochemical characterization Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009103 reabsorption Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 238000004626 scanning electron microscopy Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- -1 silicon ions Chemical class 0.000 description 1
- 238000005245 sintering Methods 0.000 description 1
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 description 1
- 229910052911 sodium silicate Inorganic materials 0.000 description 1
- 238000002336 sorption--desorption measurement Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 230000003746 surface roughness Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000008467 tissue growth Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N titanium dioxide Inorganic materials O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/02—Inorganic materials
- A61L27/12—Phosphorus-containing materials, e.g. apatite
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J27/00—Catalysts comprising the elements or compounds of halogens, sulfur, selenium, tellurium, phosphorus or nitrogen; Catalysts comprising carbon compounds
- B01J27/14—Phosphorus; Compounds thereof
- B01J27/16—Phosphorus; Compounds thereof containing oxygen, i.e. acids, anhydrides and their derivates with N, S, B or halogens without carriers or on carriers based on C, Si, Al or Zr; also salts of Si, Al and Zr
- B01J27/18—Phosphorus; Compounds thereof containing oxygen, i.e. acids, anhydrides and their derivates with N, S, B or halogens without carriers or on carriers based on C, Si, Al or Zr; also salts of Si, Al and Zr with metals other than Al or Zr
- B01J27/1802—Salts or mixtures of anhydrides with compounds of other metals than V, Nb, Ta, Cr, Mo, W, Mn, Tc, Re, e.g. phosphates, thiophosphates
- B01J27/1806—Salts or mixtures of anhydrides with compounds of other metals than V, Nb, Ta, Cr, Mo, W, Mn, Tc, Re, e.g. phosphates, thiophosphates with alkaline or alkaline earth metals
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J37/00—Processes, in general, for preparing catalysts; Processes, in general, for activation of catalysts
- B01J37/08—Heat treatment
- B01J37/082—Decomposition and pyrolysis
- B01J37/084—Decomposition of carbon-containing compounds into carbon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
Definitions
- the present invention relates to a method of obtaining biocompatible material from the drying and heat treatment of beer bagasse, as well as its use in bone tissue engineering. Therefore, from the point of view of the process, the present invention falls within the sector of the synthesis and preparation of new materials. Regarding its applications or uses, the invention falls within the health sector, and more specifically in bone tissue implants.
- the average age of the population The current development of tissue engineering is based both on the development of cultures of more or less pluripotential cell lines, inducing and regulating factors of cell differentiation, and on the development of matrices with support and structure capacity. Specifically in the development of bone regeneration, multiple models of osteoconductive characteristics, rich in phosphocalcic contents, have been designed.
- Biomaterials used must have the appropriate characteristics of composition, mechanical strength, porosity, degradation rate in the appropriate biological solutions, material transport properties and exchange of nutrients and waste products, using polymers, proteins and inorganic materials (alumina, zirconia, hydroxyapatite, calcium phosphates and bioactive glasses), mainly.
- polymers, proteins and inorganic materials alumina, zirconia, hydroxyapatite, calcium phosphates and bioactive glasses
- the solids used are synthetic (AL Oliveira, PB Malafaya, RL Reis (2003), Sodium silicate gel as a precursor for the in vitro nucleation and growth of a bone-like apatite coating in compact and porous polymeric structures, Biomaterials, 24, 2575-2584), (AG Dias, IR Gibson, JD Santos, MA Lopes (2007), Physicochemical degradation studies of calcium phosphate glass ceramic in the CaO-P2O5-MgO-TiO2 system, Acta Biomaterialia, 3, 263-269) or of animal origin, although recently the diseases related to the bovine population have raised the fear among human beings in implanting materials with such origin, being more recommended the use of materials of non-animal origin.
- Synthetic materials are often obtained by complicated synthesis of a large number of synthetic steps, using toxic reagents (eg benzoyl peroxide, benzene, anilines), with calcinations at very high temperatures close to 1500 0 C , to produce bioceramic materials, to which silicon is added to finish, by hydrolysis of TEOS, with a final sintering step at more than 1100 0 C.
- toxic reagents eg benzoyl peroxide, benzene, anilines
- the present work is based on obtaining biocompatible solids of added value using as raw material by-products of agricultural origin, carrying out processes consistent with sustainable development, that is, avoiding the use of toxic substances or procedures.
- the structure of the Final materials can be designed by changing the variables of the preparation process, so that they can be used in cell growth, according to their final textural and crystalline characteristics.
- the present invention is based on three fundamental aspects: 1) the obtaining of materials comprising phosphates and silicates, by drying and heat treating the bagasse (previous residues of the beer manufacturing process), 2) the material obtained by this procedure 3) its use in bone tissue engineering, as well as its use as a catalyst.
- the present invention is based on a process, developed by the inventors, to obtain biocompatible materials comprising phosphates and silicates from bagasse residues of beer.
- the materials obtained given their similarity to the bone mineral phase, are suitable for bone tissue engineering.
- one aspect of the present invention is the process of obtaining materials comprising phosphates and silicates, hereinafter the method of the invention, by drying and heat treating the bagasse of beer.
- beer bagasse is defined as the byproduct of
- the beer industry resulting from the pressing and filtering of the must obtained from the malted barley grain, after its saccharification.
- the bagasse of beer has a large amount of liquid, due to the processing of the original materials, and a dry matter content of 20-25%.
- a preferred aspect of the present invention is the process of the invention that is developed through the steps of: i) Drying of beer bagasse by heating from room temperature to 100-200 0 C with a temperature ramp between 1 and 10 ° C / min and maintaining the final temperature for at least two hours to stop the fermentation of the original solid. ii) Treatment of the resulting solid in i) from room temperature to a temperature within the range of 350-1200 0 C, maintaining the final temperature for more than 1 hour
- a more preferred aspect of the present invention is the process of the invention in which the final temperature of stage i) is 15O 0 C.
- Another more preferred aspect of the present invention is the process of the invention in which the final temperature of stage ii) is 85O 0 C, giving rise to a material comprising phosphorus, silicon, calcium and magnesium as main elements, in addition to lower amounts of sodium and potassium.
- the material obtained by the process of the invention, using this final temperature of 85O 0 C can be used in bone tissue engineering.
- Another more preferred aspect of the present invention is the process of the invention in which the heating ramp used in i) is 5 ° C / min.
- Another more preferred aspect of the present invention is the process of the invention in which the final temperature in stage i) is maintained for 4 hours.
- Another more preferred aspect of the present invention is the process of the invention in which the final temperature in stage ii) is maintained for 2 hours.
- Another more preferred aspect of the present invention is the process of the invention in which the final temperature of stage ii) is 35O 0 C, giving rise to a material comprising carbon, phosphorus, silicon, calcium and magnesium, in addition to amounts lower sodium and potassium.
- the material obtained by the process of the invention, using this final temperature of 35O 0 C can be used as a catalyst, absorber or semiconductor.
- Another aspect of the present invention is the material obtained by the process of the invention, hereinafter material of the invention.
- material of the invention The observation of the material of the invention with X-ray diffraction determines a crystalline structure corresponding to calcium and magnesium phosphates and silicates. Textural analysis of the material of the invention indicates the presence of macropores above 100 microns and a specific area of around 8m 2 / g. The results of chemical analysis and microwave analysis confirm the presence of phosphorus, silicon, calcium and magnesium as the main elements of the material of the invention, in addition to lower amounts of sodium and potassium.
- Another preferred aspect of the invention is the material of the invention characterized in that it mostly comprises phosphorus, silicon, calcium and magnesium, in addition to lower amounts of sodium and potassium.
- the material of the invention is suitable for the engineering of bone tissues and also its content in ions present in the physiological environment (sodium, calcium, magnesium, potassium) makes it highly biocompatible.
- ions present in the physiological environment sodium, calcium, magnesium, potassium
- the presence of phosphorus, silicon and magnesium is beneficial for tissue engineering, since phosphates are usually more soluble in biological fluids than hydroxyapatite.
- the presence of silicon is used to modify the dissolution capacity of the biomaterial, having found a greater dissolution of silicon ions and faster reabsorption in silica-calcium phosphate composites than in materials without silica.
- biologically active cations such as magnesium is a contributing factor in the properties of this type of biomaterials, since it influences the process of the subsequent biomineralization of the solid.
- Bioreabsorbable materials are important for tissue regeneration, since they do not require a second operation to remove the implant.
- Another aspect of the present invention is the use of the material of the invention in bone tissue engineering
- the material of the invention given its biocompatibility and its textural characteristics with pore diameters of several hundred microns, which can be modified by procedures designed in this regard, is useful for the growth of fat stem cells.
- a renewable material given its origin of agricultural waste, after the necessary modifications, is used for the cultivation of stem cells from fat.
- Natural coral-based materials have been used for similar purposes, although their sustainability is doubtful, since coral materials cannot be considered renewable and their presence is very important for the balance of the environment where they develop.
- the plant origin of the material of the invention from residues of the agricultural industry, prevents the possible spread of diseases that can be transmitted through the bone mass of animals.
- the material of the invention contains silicon in its composition, so it is not necessary to add it to modify the hardness and biodegradability of the final biomaterials, with the consequent economic benefit.
- Another aspect of the present invention is the use of the material of the invention as a catalyst.
- EXAMPLE 1 Preparation of biocompatible material from beer bagasse and characterization to verify its application in bone tissue engineering.
- the material obtained mainly comprises phosphorus, silicon, calcium and magnesium as the main elements, as well as lower amounts of sodium and potassium.
- the influence of its structural, surface, textural and biocompatibility characteristics on the growth of fat stem cells has been studied.
- X-ray powder diffraction was used with an X ' Pert Pro PANalytical Polycrystalline diffractometer.
- X-ray diffraction diagrams were made, with peaks between 22 and 25 ° and at 31, 33 and 34.5 2 ⁇ corresponding to tricalcium phosphate (PDF 09-0348) and calcium silicate at 29.5 ° 2 ⁇ (PDF 01 -1029).
- the apparent specific surfaces were obtained according to the BET method, assuming an area for the nitrogen molecule of 0.162 nm 2 .
- Particle size and meso and macropore distributions were determined by mercury intrusion porosimetry, after drying the samples in an oven at 150 ° C for 16 hours. For these measurements, a mercury contact angle of 141 ° and a surface tension of 484 mNm "1 according to IUPAC recommendations are assumed as standard.
- the adsorption of nitrogen in the samples gives rise to type II isotherms.
- the curve obtained in the measure of mercury intrusion porosimetry indicates particle sizes of several hundred microns.
- the porosity study reveals that the material has an open pore structure, with more than 80% of them between 100 and 300 microns in diameter.
- the bulk density of the material is 0.35 g / cc, indicating that it has a porosity of 86%.
- the skeletal density is 2.5 g / cc.
- the porosity of similar solids, taken for comparison in bibliographic searches is usually in a range of 50 to 500 microns.
- the results of textural characterization confirm that depending on the parameters used for the design of the solids, they have the capacity to serve as scaffolds in cell growth, which are confirmed by analysis performed with scanning electron microscopy.
- FTIR infrared spectroscopy
- FTIR infrared spectroscopy
- EXAMPLE 2 Preparation of biocompatible material from beer bagasse and characterization to verify its application as a catalyst, substance absorber or semiconductor.
- the beer bagasse obtained directly from the MAHOU factory in Alovera, Guadalajara, is dried by heating from room temperature to 15O 0 C with a temperature ramp of 5 ° C / min and maintaining the final temperature for four hours to stop the Ia fermentation of the original solid. Then, the resulting solid was heated from room temperature to a temperature of 350 0 C, maintaining the final temperature for 2 hours.
- the texture of this material was determined by the nitrogen adsorption-desorption technique in a Micromeritics ASAP 2010 equipment with N 2 at 77 K, subjecting the solid previously to an evacuation process for 16 hours at 300 0 C to eliminate any species that It could be weakly adsorbed on the surface.
- the apparent specific surfaces (S BET ) were obtained according to the BET method, assuming an area for the nitrogen molecule of 0.162 nm 2 [Rouquerol, F., Rouquerol J., Sing, K .; Adsorption by powders and porous solids- principies, methodology and applications, (1999), Academic Press, London].
- X-ray powder diffraction was used with an X ' Pert Pro PANalytical Polycrystalline diffractometer.
- the material obtained mainly comprises carbon, phosphorus, silicon, calcium and magnesium as the main elements, as well as lower amounts of sodium and potassium.
- S BET specific surface area
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Thermal Sciences (AREA)
- Dermatology (AREA)
- Physics & Mathematics (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Inorganic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Materials For Medical Uses (AREA)
Abstract
La présente invention concerne un procédé d'obtention de matériaux biocompatibles comprenant des phosphates et des silicates, à partir de déchets issus de l'industrie agroalimentaire, et notamment à partir du séchage et du traitement thermique de la drêche de brasserie, résidu provenant de la fabrication de la bière. L'invention concerne également l'utilisation de ces matériaux biocompatibles en ingénierie des tissus osseux.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200803331 | 2008-11-21 | ||
ESP200803331 | 2008-11-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2010058049A1 true WO2010058049A1 (fr) | 2010-05-27 |
Family
ID=42197863
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/ES2009/070475 WO2010058049A1 (fr) | 2008-11-21 | 2009-10-29 | Préparation de matériaux biocompatibles à partir de déchets issus du processus de fabrication de la bière, et utilisations de ces matériaux |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2010058049A1 (fr) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1426066A1 (fr) * | 2001-06-05 | 2004-06-09 | Yenssen Biotech Co., Ltd. | Produit d'echafaudage dans le domaine du genie tissulaire osseux humain, ses procedes de preparation et ses applications |
EP1584338A2 (fr) * | 2004-04-07 | 2005-10-12 | Millenium Biologix Inc. | Compositions d'oxyapatite substitées par le silicium |
-
2009
- 2009-10-29 WO PCT/ES2009/070475 patent/WO2010058049A1/fr active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1426066A1 (fr) * | 2001-06-05 | 2004-06-09 | Yenssen Biotech Co., Ltd. | Produit d'echafaudage dans le domaine du genie tissulaire osseux humain, ses procedes de preparation et ses applications |
EP1584338A2 (fr) * | 2004-04-07 | 2005-10-12 | Millenium Biologix Inc. | Compositions d'oxyapatite substitées par le silicium |
Non-Patent Citations (3)
Title |
---|
CLARK ET AL.: "Catalytic performance of carbonaceus materials in the esterification of succinic acid catalysis.", COMMUNICATIONS, vol. 9, 2008, pages 1709 - 1714 * |
DOSORETZ, C.G. ET AL.: "Removal of trace organics from water using pumped bed-membrane bioreactor with powdered activated carbon.", JOURNAL OF MEMBRANE SCIENCE, vol. 239, August 2004 (2004-08-01), pages 81 - 90 * |
MAITI, S. ET AL.: "Silicon-doped carbon semiconductors fron rice husk char.", MATERIALS CHEMISTRY AND PHYSICS, vol. 109, 15 May 2008 (2008-05-15), pages 169 - 173 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Jones et al. | Optimising bioactive glass scaffolds for bone tissue engineering | |
Zhu et al. | Preparation, characterization and in vitro bioactivity of mesoporous bioactive glasses (MBGs) scaffolds for bone tissue engineering | |
Tadic et al. | A novel method to produce hydroxyapatite objects with interconnecting porosity that avoids sintering | |
Scalera et al. | Influence of the calcination temperature on morphological and mechanical properties of highly porous hydroxyapatite scaffolds | |
Swain et al. | Preparation of porous scaffold from hydroxyapatite powders | |
RU2354408C2 (ru) | Неорганический резорбируемый материал для замены костей | |
Rainer et al. | Fabrication of bioactive glass–ceramic foams mimicking human bone portions for regenerative medicine | |
KR102258806B1 (ko) | 재생의학 재료 및 그의 제조방법과 응용 | |
Huang et al. | Highly porous and elastic aerogel based on ultralong hydroxyapatite nanowires for high-performance bone regeneration and neovascularization | |
Arcos et al. | Mesoporous bioactive glasses: Mechanical reinforcement by means of a biomimetic process | |
Mbarki et al. | Hydroxyapatite bioceramic with large porosity | |
Mazón et al. | Porous scaffold prepared from α′ L-Dicalcium silicate doped with phosphorus for bone grafts | |
Lett et al. | Porous hydroxyapatite scaffolds for orthopedic and dental applications-the role of binders | |
KR101558856B1 (ko) | 뼈 대체 재료 | |
Ros-Tárraga et al. | New 3D stratified Si-Ca-P porous scaffolds obtained by sol-gel and polymer replica method: Microstructural, mineralogical and chemical characterization | |
Zhang et al. | Biodegradable elastic sponge from nanofibrous biphasic calcium phosphate ceramic as an advanced material for regenerative medicine | |
KR20160032230A (ko) | 골형성 유도 인산 칼슘의 제조방법 및 이로부터 제조된 제품 | |
Qian et al. | Fabrication, chemical composition change and phase evolution of biomorphic hydroxyapatite | |
Lu et al. | Preparation, bioactivity, degradability and primary cell responses to an ordered mesoporous magnesium–calcium silicate | |
Tang et al. | LAPONITE® nanorods regulating degradability, acidic-alkaline microenvironment, apatite mineralization and MC3T3-E1 cells responses to poly (butylene succinate) based bio-nanocomposite scaffolds | |
CN114630685A (zh) | 医疗用碳酸钙组合物及相关医疗用组合物、以及它们的制造方法 | |
Jie et al. | Preparation of macroporous sol-gel bioglass using PVA particles as pore former | |
JP2010523232A (ja) | パイロジェンフリーのリン酸カルシウムの生産方法 | |
CN114761048A (zh) | 骨替代材料的胶原基质或颗粒共混物 | |
WO2010058049A1 (fr) | Préparation de matériaux biocompatibles à partir de déchets issus du processus de fabrication de la bière, et utilisations de ces matériaux |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09827210 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 09827210 Country of ref document: EP Kind code of ref document: A1 |